Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Global multi‐specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers
Rodda, Joanne , Kuchenbecker, Lindsey A. , Chabrashvili, Tinatin, Budelier, Melissa M. , Duran‐Aniotz, Claudia , Udeh‐Momoh, Chinedu , Akman‐Anderson, Leyla, Pereira, Ana C. , Keshavan, Ashvini , Keshavan, Ashvini , Borelli, Wyllians Vendramini , DeMarco, Mari L. , Castilhos, Raphael Machado , Cawston, Erin E. , Mielke, Michelle M. , Algeciras‐Schimnich, Alicia

Alzheimer's & Dementia | May 22, 2025 | Volume: 21 | Issue: 5 | Pages: No page available

10.1002/alz.70201 | PMID 40401661 Get It

Abstract INTRODUCTION Clinicians’ views on the clinical readiness of Alzheimer's disease (AD) blood biomarkers (BBMs) are not well understood. METHODS The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment Biofluid‐Based Biomarkers Professional Interest Area conducted a survey to elicit clinician opinions on AD BBM implementation, including contexts of use, assay selection, reporting, and result interpretation. RESULTS Clinician respondents ( n = 212) practiced in Europe (56%), North America (24%), the Caribbean and Central/South America (11%), and other continents (9%). Most respondents were medical doctors (80%) practicing in secondary or tertiary care (88%). For 56%, cerebrospinal fluid AD biomarkers or amyloid positron emission tomography were accessible, but 48% agreed and 52% disagreed with the implementation of AD BBMs in any clinical context. Respondents emphasized the need for data from diverse populations and educational resources to support test interpretation. DISCUSSION Surveyed clinicians generally agreed with published appropriate use recommendations but were divided on AD BBM readiness for clinical use. Highlights A survey of clinicians was conducted regarding clinical readiness of Alzheimer's disease (AD) blood biomarkers (BBMs). Views were split on AD BBM clinical readiness: 48% agreed, 52% disagreed. Most responders supported AD BBM use for treatment decisions. Most responders opposed AD BBM testing in asymptomatic individuals. Test performance data and educational materials to aid interpretation were of high importance.
Beyond the Impact of Cadaveric Donor Transplant on Chronic Rhinosinusitis and Recalcitrant Disease
Candelo, Estephanía , Bohorquez‐Caballero, Anyull D. , Avila‐Castano, Karol , Donaldson, Angela M. , Wadei, Hani, Donaldson, Angela M , Gomez, Estephania Candelo , Caballero, Anyull D. B. , Wadei, Hani M.

International Forum of Allergy & Rhinology | May 22, 2025 | Volume: 15 | Issue: 6 | Pages: 671-672

10.1002/alr.23593 | PMID 40401552 Get It

Streamlining Thoracic Radiotherapy Quality assurance: One-Class Classification for Automated OAR Contour Assessment
Zhao, Yihao , Yuan, Cuiyun, Liang, Ying , Li, Yang , Li, Chunxia , Zhao, Man, Hu, Jun , Zhong, Ningze , Liu, Wei , Liu, Chenbin , Liu, Wei

Technology in Cancer Research & Treatment | May 22, 2025 | Volume: 24 | Issue: No issue available | Pages: No page available

10.1177/15330338251345895 | PMID 40400421 Get It

Purpose Automating quality assurance (QA) for contours generated by automatic algorithms is critical in radiotherapy treatment planning. Manual QA is tedious, time-consuming, and prone to subjective experiences. Automatic segmentation reduces physician workload and improves consistency. However, an effective QA process for these automatic contours remains an unmet need in clinical practice. Materials and Methods The patient data used in this study was derived from the AAPM Thoracic Auto-Segmentation Challenge dataset, including left and right lungs, heart, esophagus, and spinal cord. Two groups of organ-at-risk (OAR) were generated. A ResNet-152 network was used as a feature extractor, and a one-class support vector machine (OC-SVM) was employed to classify contours as ‘high’ or ‘low’ quality. To evaluate the generalizability, we generated low-quality contours using translation and resizing techniques and assessed correlations between detection limits and metrics such as volume, Dice similarity coefficient (DSC), 95% Hausdorff distance (HD95), and mean surface distance (MSD). Results The proposed OC-SVM model outperformed binary classifiers n metrics such as balanced accuracy and area under the receiver operating characteristic curve (AUC) . It demonstrated superior performance in detecting various types of contour errors while maintaining high interpretability. Strong correlations were observed between detection limits and contour metrics. Conclusion Our proposed model integrates an attention mechanism with a one-class classification framework to automate QA for OAR delineations. This approach effectively detects diverse types of contour errors with high accuracy, significantly reducing the burden on physicians during radiotherapy planning.
In-Home Assistive Technology May Help Protect Dementia Caregivers from Declining Sleep Efficiency: A Randomized Control Trial
Scheffer, Julian A. , Levan, Darius Tran, Gallagher‐Thompson, Dolores , Chen, Kuan‐Hua , Brown, Casey K., Bullard, Breanna M. , Newton, Scott L. , Chen, Enna Y., Merrilees, Jennifer , Wang, Gene, Levenson, Robert W. , Gallagher-Thompson, Dolores , Yee, Claire I., Levenson, Robert W , Wells, Jenna L. , Grimm, Kevin J. , Brown, Casey K., Yee, Claire , Moss, David

Clinical Gerontologist | May 22, 2025 | Volume: 48 | Issue: 5 | Pages: 1112-1125

10.1080/07317115.2025.2499812 | PMID 40400304 Get It

Macrowire-only direct aspiration first-pass technique for endovascular mechanical thrombectomy: Multicenter technical series using the 0.035″ aristotle Colossus wire
Ares, William J. , Tonetti, Daniel A. , Koneru, Manisha , Dalkilic, Ahmet, Salah, Walid K. , Brinjikji, Waleed , Rajjoub, Kenan , Raz, Eytan, Khawaja, Ayaz , Southwood, Christopher, Dalyai, Richard , Birnbaum, Lee , Chowdhry, Shakeel , M., Huy , Joyce, Evan, Calnan, Daniel R. , Malek, Adel M. , Ares, William J , Tonetti, Daniel , Malek, Adel , Grandhi, Ramesh , Dalkilic, Ahmet, Raz, Eytan , Grandhi, Ramesh

Interventional Neuroradiology | May 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15910199251343117 | PMID 40400317 Get It

Background Larger “macrowires” may facilitate microcatheter-free delivery of large-bore aspiration catheters (ACs) for intracranial endovascular mechanical thrombectomy. We examined the safety and efficacy of the Aristotle Colossus Guidewire for this use. Methods In this retrospective analysis of prospective data from 12 institutions, we identified anterior circulation endovascular mechanical thrombectomy cases involving the Aristotle Colossus guidewire over a 12-month period. The primary efficacy endpoint was successful delivery of the AC to the site without the use of adjunct devices. Multivariable logistic regression was performed with clinically relevant covariables. Results In 122 patients (median age 74 years (interquartile range (IQR) 63–82)), most intracranial occlusions were in the M1 segment of the middle cerebral artery (95/122, 78.0%). The primary endpoint of microcatheter-free AC delivery was met in 87.7% (107/122) of patients; 93/122 (76.2%) patients underwent microcatheter-free delivery with successful reperfusion via contact aspiration (modified thrombolysis in cerebral infarction grade ≥ 2B). The median number of passes was 1 (IQR 1–2). Multivariable regression demonstrated that severe internal carotid artery tortuosity or cervical loop presence (odds ratio (OR): 0.09, 95% confidence interval (CI): 0.01–0.54, p = 0.01) and presence of intracranial atherosclerotic disease (OR: 0.15, 95% CI: 0.03–0.83, p = 0.03) were significantly associated with lower odds of successful AC delivery over the guidewire. Intraprocedural vasospasm occurred in 4.9% (6/122) of cases; there were no reports of vessel dissection or perforation. Conclusions We demonstrate the favorable performance of the Aristotle Colossus guidewire for anterior circulation ischemic stroke intervention. The macrowire appears to safely facilitate navigation of the neurovasculature by large-bore ACs without the need for microcatheter and/or stentriever.
Safety in a hybrid hospital‐at‐home program versus traditional inpatient care: A pragmatic randomized controlled trial
Maniaci, Michael J. , Sangaralingham, Lindsey R. , Behnken, Emma , Hart, Melissa S., Inselman, Shealeigh A., Nelson, Chad R. , Gothot, Rachel A., Smith, Y.R., Oloyede, Sey V. , Gifford, Sarah L., Taylor, Josh D., Dunn, Ajani N., Dowdy, Sean C. , Bosch, Wendelyn , Cowart, Jennifer B. , Behnken, Emma M, Paulson, Margaret, Nelson, Chad R , Chang, Yu‐Hui H., Hanson, Kristine T. , Larson Smith, Yvonne M, Dunlay, Shannon M. , Habermann, Elizabeth , Cowart, Jennifer B , Yao, Xiaoxi , Maniaci, Michael J , Inselman, Shealeigh A., Paulson, Margaret R. , Chang, Yu‐Hui , Smith, Yvonne M. Larson, Taylor, Josh D., Habermann, Elizabeth B. , Yao, Xiaoxi

Journal of Hospital Medicine | May 22, 2025 | Volume: 20 | Issue: 11 | Pages: 1174-1184

10.1002/jhm.70076 | PMID 40400147 Get It

Abstract Background Hospital‐at‐home programs (HaH) in the United States have evolved to include a virtual‐hybrid delivery model, where all physician encounters are virtual and partnered with a home care team. Objective To examine whether a virtual hybrid HaH program enabled by technology has similar clinical outcomes to traditional brick‐and‐mortar (B&M) hospital care. Methods We conducted a pragmatic trial at three hospitals, randomizing 1150 acutely ill patients requiring hospital care between July 10, 2023, and October 31, 2023 one‐to‐one into two groups: intervention (HaH) and control (B&M). The primary analysis was an intention‐to‐treat non‐inferiority analysis of the primary outcome, which was a composite of 30‐day all‐cause mortality and unplanned readmissions. Secondary outcomes included 30‐day readmission, all‐cause mortality, and patient experience. Results The mean age was 67.8 (standard deviation [SD] 16.3) years, and 52.2% were female. The primary outcome occurred in 99 (17.3%) HaH patients and 114 (19.8%) B&M patients (odds ratio [OR] 0.85, 95% confidence interval [CI] 0.63–1.14, p = .28), meeting the non‐inferiority criterion. Thirty‐day unplanned readmission occurred in 84 (14.7%) HaH patients and 101 (17.5%) B&M patients (OR 0.81, 95% CI 0.59–1.11, p = .19). Thirty‐day all‐cause mortality occurred in 25 (4.4%) HaH patients and 19 (3.3%) B&M patients (OR 1.34, 95% CI 0.73–2.46, p = .35). No HaH patients died while receiving their hospital care at home. HaH program was associated with a higher likelihood of patients reporting feeling extremely comfortable or very comfortable (84.4% HaH; 60.9% B&M, p = .001). Conclusion A hybrid HaH model is a safe and comfortable alternative to traditional B&M hospital care.
Effects of buprenorphine on pain perception in healthy adults: a meta-narrative systematic review
Hooten, W. Michael , Zheng, Danielle, Canzanello, Nicholas , Eberhart, Nathan D., Benkli, Barlas , Hirani, Salman, Canzanello, Nicholas C, Moman, Rajat N. , Prokop, Larry J. , Hirani, Salman

PAIN Reports | May 22, 2025 | Volume: 10 | Issue: 3 | Pages: e1294

10.1097/pr9.0000000000001294 | PMID 40401084 Get It

Abstract The availability of knowledge about the effects of buprenorphine on pain perception in healthy adults could help investigators select experimental tests with evidence of responsiveness to buprenorphine in nondiseased states. The purpose of this meta-narrative systematic review is to summarize the effects of buprenorphine on pain perception in healthy adults. Comprehensive database searches were conducted from inception dates through July 16, 2024. Inclusion criteria included all study designs involving healthy adults receiving buprenorphine and tests of pain perception. Risk of bias was assessed using a tool developed for randomized controlled trials (RCTs). A meta-narrative approach was used due to high levels of clinical heterogeneity. A total of 10 RCTs were included, and healthy adults comprised the comparator groups in all trials. Three RCTs had a low risk of bias, 6 had some concerns, and 1 had a high risk of bias. Six RCTs used intravenous buprenorphine, 3 used transdermal, and 1 study used intravenous and sublingual buprenorphine. The effects of buprenorphine on pain perception are influenced by the route of administration, dose, and pain stimulus modality. Considerable differences exist in the effects of intravenous and transdermal buprenorphine, but only 1 study used sublingual buprenorphine, which limited comparison with the other drug formulations. Based on these findings, recommendations for clinical trials are proposed. These recommendations should be cautiously interpreted due to the clinical heterogeneity, but they provide a framework for advancing the use of experimental pain tests in trials of buprenorphine involving comparator groups of healthy adults.
The Role and Performance of Postoperative Imaging After Repair of a Perforated Peptic Ulcer
Strajina, Veljko , Lund, Sarah , Zhu, Rebecca, Stephens, Daniel , Zietlow, John , Heller, Stephanie F. , Turay, David, Mahmoud, Khalid , Harmsen, William S. , Ahmed, Amin Mohamed , Lund, Sarah B, Zietlow, John M, Mahmoud, Khalid H., Mohamed Ahmed, Amin, Khandelwal, Ashish , Stephens, Daniel

World Journal of Surgery | May 21, 2025 | Volume: 49 | Issue: 8 | Pages: 2116-2122

10.1002/wjs.12622 | PMID 40399251 Get It

ABSTRACTBackgroundWe aimed to determine the performance of postoperative computed tomography (CT) and upper gastrointestinal series (UGI) in patients who underwent surgery for a perforated peptic ulcer and to assess the yield of routine postoperative studies.MethodsRetrospective, single‐institution, chart‐review study of patients who underwent a repair of a perforated gastric or duodenal ulcer between August 2004 and September 2021 at Mayo Clinic, Rochester, Minnesota.ResultsWe identified a total of 240 patients, 28 (12%) were found to have leaks. When any of the four findings (extraluminal gas or fluid collection adjacent to the repair, worsening pneumoperitoneum, or enteral contrast extravasation) was present on postoperative CT scan (n = 116) it had sensitivity of 76% (95% CI 53%–90%), with a specificity of 90% (95% CI 84%–91%). Upper gastrointestinal series (UGI, n = 150) showed a sensitivity of 57% (95% CI 25%–84%) and a specificity of 99% (95% CI 96%–100%). UGI demonstrated higher specificity compared to CT (p < 0.01); there was no significant difference in sensitivity (p = 0.34). The findings from CT scans led to changes in management for a significantly greater number of patients compared to UGI (20% vs. 4%, p < 0.01). The diagnostic yield for leak identification was 3% for routine postoperative CT (n = 63) and 2% for routine UGI studies (n = 141).ConclusionsPostoperative CT is more likely to change management in patients who underwent repair of a perforated peptic ulcer compared to postoperative upper gastrointestinal series. The yield of routine postoperative studies is low, and their benefit is uncertain.
Effect of low-dose colchicine on pericoronary inflammation and coronary plaque composition in chronic coronary disease: a subanalysis of the LoDoCo2 trial
Fiolet, Aernoud T L , Lin, Andrew , Kwieciński, Jacek , Nolthenius, Julie Tutein, McElhinney, Priscilla , Grodecki, Kajetan , Kietselaer, Bas , Opstal, Tjerk S.J. , Cornel, Jan H. , Knol, Remco J.J. , Schaap, Jeroen , Aarts, Ruud A H M, Nolthenius, Annemieke M F A Tutein, Nidorf, Stefan M. , Dey, Damini , Dey, Damini , Kietselaer, Bas L J H , Fiolet, Aernoud T L , Velthuis, Birgitta K. , Mosterd, Arend

Heart | May 21, 2025 | Volume: 111 | Issue: 23 | Pages: 1156-1163

10.1136/heartjnl-2024-325527 | PMID 40393691 Get It

Background Low-dose colchicine (0.5 mg once daily) reduces the risk of major cardiovascular events in coronary disease, but its mechanism of action is not yet fully understood. We investigated whether low-dose colchicine is associated with changes in pericoronary inflammation and plaque composition in patients with chronic coronary disease. Methods We performed a cross-sectional, nationwide, subanalysis of the Low-Dose Colchicine 2 Trial (LoDoCo2, n=5522). CT angiography studies were performed in 151 participants randomised to colchicine or placebo after a median treatment duration of 28.2 months. Pericoronary adipose tissue (PCAT) attenuation measurements around proximal coronary artery segments and quantitative plaque analysis for the entire coronary tree were performed using artificial intelligence-enabled plaque analysis software. Results Median PCAT attenuation was not significantly different between the two groups (−79.5 Hounsfield units (HU) for colchicine versus −78.7 HU for placebo, p=0.236). Participants assigned to colchicine had a higher volume (169.6 mm 3 vs 113.1 mm 3 , p=0.041) and burden (9.6% vs 7.0%, p=0.035) of calcified plaque, and higher volume of dense calcified plaque (192.8 mm 3 vs 144.3 mm 3 , p=0.048) compared with placebo, independent of statin therapy. Colchicine treatment was associated with a lower burden of low-attenuation plaque in participants on a low-intensity statin, but not in those on a high-intensity statin (p interaction =0.037). Conclusions Pericoronary inflammation did not differ among participants who received low-dose colchicine compared with placebo. Low-dose colchicine was associated with a higher volume of calcified plaque, particularly dense calcified plaque, which is considered a feature of plaque stability.